Stocks
Aspira Women's Health (AWH) R&D/CAPEX US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2022 | 2023 | 2023 | LTM ? | CAGR 5 years ? | |||
| R&D/CAPEX, % | 2 888% | 2 566% | 2 566% | 16 813% | 8 270% | ||||
| Changes by years, y/y, % | +2 459pp | -322pp | 0pp | -2 566pp | +103.1% | ||||
Aspira Women's Health. R&D/CAPEX, %
Aspira Women's Health. R&D/CAPEX, changes, pp
Aspira Women's Health (AWH) R&D/CAPEX US GAAP (quarter values) |
||||||||
| 2023Q4 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q2 | LTM ? | |||
| R&D/CAPEX, % | 8 975% | 4 530% | 6 347% | 8 270% | ||||
| Changes by years, y/y, % | -1 403pp | +7 572pp | -10 858pp | -17 325pp | -10 978pp | |||
| Changes by quarters, q/q, % | -4 445pp | -4 530pp | ||||||
